Characterized primarily by a low body-mass index, anorexia nervosa is a complex and serious illness 1 , affecting 0.9-4% of women and 0.3% of men [2] [3] [4] , with twin-based heritability estimates of 50-60%
. These r g analyses pointed toward metabolic etiological factors, as they are robust to reverse causation, although they could be mediated associations 11 or reflect confounding processes 12 . To advance genomic discovery in anorexia nervosa and further explore genetic correlations, we combined samples from ANGI 8, 9 , the Genetic Consortium for Anorexia Nervosa (GCAN)/Wellcome Trust Case Control Consortium-3 (WTCCC-3) 13 and the UK Biobank 14 , quadrupling our sample size. Our GWAS meta-analysis included 33 datasets comprising 16,992 cases and 55,525 controls of European ancestry from 17 countries (Supplementary Tables 1-4) . We had 80% power to detect an odds ratio of 1.09-1.19 (additive model, 0.9% lifetime risk, α = 5 × 10 −8
, minor allele frequency (MAF) = 0.05-0.5). Typical of complex-trait GWAS, we observed test statistic inflation (λ = 1.22) consistent with polygenicity, with no evidence of significant population stratification according to the linkage disequilibrium (LD) intercept and attenuation ratio (Supplementary Note and Supplementary  Fig. 1 ). Meta-analysis results were completed for autosomes and the X chromosome. We identified eight loci that exceeded genome-wide significance (P < 5 × 10 ; Table 1 for loci; Fig. 1 for the Manhattan plot; Supplementary Figs. 2 and 3 for the forest and region plots, respectively). Many loci were near the threshold for significance, and no significant heterogeneity of SNP associations across cohorts was detected (P = 0.15-0.64; Supplementary Fig. 2 ). Conditional and joint analysis (GCTA-COJO) 15 confirmed independence of the lead SNPs within the significant loci (Supplementary Table 5 ). The eight loci were annotated to identify known protein-coding genes (Supplementary Table 6; Supplementary Table 7 reports a gene search restricted to the single-gene loci). The previously reported PGC-ED genome-wide significant variant (rs4622308) 10 on 12q13.2 did not reach genome-wide significance (P = 7.02 × 10 ); however, betweencohort heterogeneity was apparent (I 2 = 53.7; Supplementary Fig. 4 and Supplementary Note). The odds ratio was in the same direction in 22 (67%) of the cohorts (z = 2.00, P = 0.05, two-tailed test).
Although GWAS findings are informative genome-wide, identifying strong hypotheses about their connections to specific genes is not straightforward. We evaluated three ways to connect anorexia nervosa-associated loci identified by GWAS to genes: regulatory chromatin interactions, relationship to brain expression quantitative trait loci (eQTLs; using a superset of CommonMind 16 and GTEx
17
) and the standard approach of gene location within a GWAS locus. The significant anorexia nervosa-associated loci implicated 121 brain-expressed genes, 74% by location, 55% by adult brain eQTL analysis, 93% by regulatory chromatin interaction and 58 genes by all three methods. Supplementary Figure 5 shows the eight GWAS loci, GENCODE gene models, adult brain regulatory chromatin interactions, brain eQTLs and functional genomic annotations.
Four single-gene loci were confirmed by eQTL analyses, chromatin interaction studies or both. These were the locus-intersecting genes CADM1 (locus 2, chromosome 11: 114.9-115. 4 Mb, Supplementary Fig. 5b ), MGMT (locus 4, chromosome 10: 131.2-131. 4 Mb, Supplementary Fig. 5d ), FOXP1 (locus 5, chromosome 3: 70.6-71.0 Mb, Supplementary Fig. 5e ) and PTBP2 (locus 6, chromosome 1: 96.6-97.2 Mb, Supplementary Fig. 5f ). For locus 5, eQTL data implicated a distal gene, GPR27. One intergenic locus (locus 7, chromosome 5: 24.9-25.3 Mb, Supplementary Fig. 5g ) had no eQTL or chromatin interactions, whereas the other intergenic locus (locus 8, chromosome 3: 93.9-95.0 Mb, Supplementary Fig. 5h ) had eQTL connections to PROS1 and ARL13B. Two complex multigenic loci had many brain-expressed genes and dense chromatin and eQTL interactions that precluded identification of any single gene (locus 1, chromosome 3: 47.5-51.3 Mb; locus 3, chromosome 2: 53.8-54.3 Mb, Supplementary Fig. 5a ,c). The clearest evidence and connections were for the single-gene loci that intersected with CADM1, MGMT, FOXP1 and PTBP2, and we conclude that these genes may have a role in the etiology of anorexia nervosa (Supplementary Note).
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Supplementary Table 8 presents multi-trait analysis (GCTAmtCOJO 18 ; conditioning our genome-wide significant SNPs on associated variants in GWAS of body-mass index (BMI), type 2 diabetes, education years, high-density lipoprotein (HDL) cholesterol, neuroticism and schizophrenia. Seven loci appear to be independent. Locus 2 on chromosome 11 may not be unique to anorexia nervosa and may be driven by genetic variation also associated with type 2 diabetes.
Liability-scale SNP heritability (SNP-h 2 ) was estimated using LD score regression (LDSC) 19, 20 . Assuming a lifetime prevalence 2-4 of 0.9-4%, SNP-h 2 was 11-17% (s.e. = 1%), supporting the polygenic nature of anorexia nervosa. Polygenic risk score (PRS) analyses using a leave-one-out approach indicated that the PRS captures approximately 1.7% of the phenotypic variance on the liability scale for discovery P = 0.5. We did not observe differences in polygenic architecture between anorexia nervosa subtypes with binge eating (2,381 cases, 10,249 controls) or without (2,262 cases, 10,254 controls), or between males (447 cases, 20,347 controls) and females (14,898 cases, 27,545 controls) (Methods, Supplementary Note, Supplementary Fig. 6 and Supplementary Table 9 ). Similar to females, males in the highest PRS decile had 4.13 (95% confidence interval: 2.58-6.62) times the odds of anorexia nervosa than those The results of the GWAS meta-analysis of anorexia nervosa (16,992 cases and 55,525 controls) are shown, in which eight novel genome-wide significant loci were detected. Chromosome and region (based on hg19) are shown for SNPs with P < 1 × 10 −5 and LD-r 2 > 0.1 with the most associated lead SNP, the location of which is given (base pair). A1/A2 refers to allele 1/allele 2. The odds ratio (OR) and s.e. are shown for the association between allele 1 and the phenotype. Frequency indicates the frequency of allele 1 in controls. The number of genes was determined by genomic location, adult brain eQTL, regulatory chromatin interactions and MAGMA gene-wise analysis (see Methods). The nearest gene is the nearest gene within the region of LD 'friends' of the lead variant (LD-r 2 > 0.6 ± 500 kb). The meta-analysis was restricted to variants with MAF ≥ 0.01 and information quality (INFO) score ≥ 0.70. All loci were confirmed using forest plots based on consistent direction of effect in the majority of cohorts and using region plots in which neighboring LD friends were required to show a similar effect. Chromosome X was analyzed but had no loci that reached genome-wide significance. Note, although lead variants are annotated to the nearest gene, this does not mean that the gene listed is a causal gene. The −log 10 (P) values for the association tests (two-tailed) are shown on the y axis and the chromosomes are ordered on the x axis. Eight genetic loci surpassed the genome-wide significance threshold (−log 10 (P) > 7.3; indicated by the line). The lead variant is indicated by a diamond, and green circles show the variants in LD. The blue and red colors differentiate adjacent chromosomes.
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Nature GeNetics in the lowest decile. However, confirmation of these results requires larger samples. We tested SNP-based genetic correlations (SNP-r g ) with external traits using bivariate LDSC 19, 20 . Bonferroni-significant SNP-r g assorted into five trait categories: psychiatric and personality, physical activity, anthropometric traits, metabolic traits and educational attainment (Supplementary Table 10 ). ). This pattern reflects observed comorbidities in clinical and epidemiological studies 21, 22 . The newly identified positive SNP-r g association with physical activity (0.17 ± 0.05; P = 1.00 × 10 ) encourages further exploration of the refractory symptom of pathologically elevated activity in anorexia nervosa 23 . We note that the significant SNP-r g of anorexia nervosa with educational attainment (0.25 ± 0.03; P = 1.69 × 10 ) and related constructs was not seen for IQ 24 . Expanding our previous observations 10 , we present a number of metabolic and anthropometric r g with anorexia nervosa that are more pronounced than in other psychiatric disorders. We observed significant negative SNP-r g with fat mass (−0.33 ± 0.03; P = 7.23 × 10 Table 11 ), the expression of which increases in response to food restriction in a rodent activity-based anorexia nervosa model 25 . Partitioned heritability analysis showed, as with other GWAS 26 , considerable enrichment of SNP-h 2 in conserved regions 27 (fold enrichment = 24.97, s.e. = 3.29, P = 3.32 × 10 −11 ; Supplementary  Fig. 7 ). Cell type group-specific annotations revealed that the overall SNP-h 2 is significantly enriched for tissues of the central nervous system (Supplementary Fig. 8 ). One biological pathway was significant, Gene Ontology (GO): positive regulation of embryonic development (32 genes, P = 1.39 × 10 −7 ; Supplementary Table 12), which contains two Bonferroni-corrected significant genes on chromosome 3, CTNNB1 and DAG1. CTNNB1 encodes catenin β-1, which is part of adherens junctions and a component of Wnt signaling, and DAG1 encodes dystroglycan, a receptor that binds extracellular matrix proteins 28 . DAG1 falls within locus 1 (47.5-51.3 Mb). This pathway points to a potential role of developmental processes in the etiology of this complex phenotype (although this is currently speculative). Genes associated with anorexia nervosa were enriched for expression in most brain tissues, particularly Letters Nature GeNetics the cerebellum, which has a notably high proportion of neurons 29 ( Supplementary Fig. 9 ). Among 24 brain cell types from mouse brain, significant enrichment was found for medium spiny neurons and pyramidal neurons from hippocampal CA1 ( Supplementary  Fig. 10 ). Both medium spiny and pyramidal neurons are linked to feeding behaviors, including food motivation and reward 30, 31 (Supplementary Note). Using PrediXcan (Supplementary Note), 36 genes were predicted to be differentially expressed in GTEx tissues or blood (Supplementary Table 13) , with the expression of MGMT predicted to be downregulated in the caudate. We cautiously note that these results represent the first indications of specific pathways, tissues and cell types that may mediate genetic risk for anorexia nervosa.
Because low BMI is pathognomonic of anorexia nervosa, we investigated the extent to which genetic variants associated with BMI accounted for genetic correlations with metabolic and anthropometric traits. First, covarying for the genetic associations of BMI (Methods) led to a mild but statistically non-significant attenuation of the SNP-r g between anorexia nervosa and fasting insulin, leptin, insulin resistance, type 2 diabetes and HDL cholesterol (Supplementary Tables 14, 15 ), suggesting that anorexia nervosa shares genetic variation with these metabolic phenotypes that may be independent of BMI. Second, we investigated bidirectional causality using generalized summary data-based Mendelian randomization (GSMR) 18 . This indicated a significant bidirectional causal relationship such that anorexia nervosa risk-increasing alleles may increase the risk for low BMI, and BMI-lowering alleles may increase the risk of anorexia nervosa (Supplementary Table 16 ). It is important to note that having only eight genome-wide significant loci for anorexia nervosa render this analysis marginally powered in the direction of anorexia nervosa to BMI, although this analysis is well-powered in the direction of BMI to anorexia nervosa.
Replication is challenging with GWAS of low-prevalence conditions, such as anorexia nervosa, as replication samples must be sufficiently powered to detect the initial findings. We included all available samples in our analysis to maximize chances of reaching the GWAS inflection point, after which there might be a linear increase in hits 32 . The PRS leave-one-out analyses provide evidence of replication by demonstrating a higher burden of common risk variants associated with anorexia nervosa cases, compared with controls, across all the cohorts ( Supplementary Fig. 16 ).
In conclusion, we report multiple genetic loci alongside promising clinical and functional analyses and enrichments. The increased sample size in the present GWAS has allowed us to characterize more fully the metabolic contribution to anorexia nervosa than our previous report 10 by revealing significant r g with metabolism-related phenotypes, including glycemic and anthropometric traits, and by demonstrating that the effect is robust to correction for the effects of common variants significantly associated with BMI. Low BMI has traditionally been viewed as a consequence of the psychological features of anorexia nervosa (that is, drive for thinness and body dissatisfaction). This perspective has failed to yield interventions that reliably lead to sustained weight gain and psychological recovery 7 . Fundamental metabolic dysregulation may contribute to the exceptional difficulty that individuals with anorexia nervosa have in maintaining a healthy BMI (even after therapeutic renourishment). Our results encourage consideration of both metabolic and psychological drivers of anorexia nervosa when exploring new avenues for treating this frequently lethal illness.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of code and data availability and associated accession codes are available at https://doi.org/10.1038/ s41588-019-0439-2. 10 , newly collected samples from the ANGI 8, 9 , archived samples from the GCAN/WTCCC3 13 , samples from cases of anorexia nervosa from the UK Biobank 14 , and additional controls from Poland. Case definitions established a lifetime diagnosis of anorexia nervosa via hospital or register records, structured clinical interviews, or online questionnaires based on standardized criteria (Diagnostic and Statistical Manual of Mental Disorders (DSM) III-R, DSM-IV, International Classification of Diseases (ICD) 8, ICD-9 or ICD-10), whereas in the UK Biobank, cases self-reported a diagnosis of anorexia nervosa. Controls were carefully matched for ancestry, and some, but not all, control cohorts were screened for lifetime eating and/or some or all psychiatric disorders. Given the relative rarity of anorexia nervosa, large unscreened control cohorts were deemed appropriate for inclusion 33 . The cohorts are described in the Supplementary Note. Ethical approvals and consent forms were reviewed and archived for all participating cohorts (see Supplementary Note for Danish methods). Summary details about ascertainment (Supplementary Table 2 ), the genotyping platforms used (Supplementary Table 3 ) and genotype availability (Supplementary Table 4 ) are provided.
Statistical analysis. Data processing and analysis were done on the Lisa Compute
Cluster hosted by SURFsara (http://www.surfsara.nl) and the GenomeDK highperformance computing cluster (http://genome.au.dk).
Meta-analysis of genome-wide association data. Quality control, imputation, GWAS and meta-analysis followed the standardized pipeline of the PGC, Ricopili (Rapid Imputation Consortium Pipeline). Ricopili versions used were 2017_Oct_11.002 and 2017_Nov_30.003. Quality control included SNP and sample quality control, population stratification and ancestry outliers, and familial and cryptic relatedness. Further information about the Ricopili pipeline is available from the website (https://sites.google.com/a/broadinstitute.org/ricopili) and GitHub repository (https://github.com/Nealelab/ricopili/tree/master/rp_bin). Further details of the quality control procedures can be found in the Supplementary Note.
Imputation. Imputation of SNPs and insertions-deletions was based on the 1000
Genomes Phase 3 (http://www.internationalgenome.org) data 34 .
GWAS. GWASs were conducted separately for each cohort using imputed variant dosages and an additive model. Covariates nominally associated with the phenotype in univariate analysis (P < 0.05) and five ancestry principal components were included in the GWAS (Supplementary Table 18 ). These analyses used the tests and methods programmed in the Ricopili pipeline. To the extent that national laws and regulations permitted, we examined sample overlap across cohorts by performing LD score bivariate regressions and estimating genetic covariance intercepts to assess sample overlap 19, 20 (Supplementary Table 19 ). Genomic inflation factors (λ) of the final datasets indicated no evidence of inflation of the test statistics due to population stratification or other sources (Supplementary Table 1 ). The 33 cohorts were meta-analyzed with the Ricopili pipeline, which uses an inverse-variance weighted fixed-effect model. We filtered our GWAS results with MAF ≥ 0.01 and INFO score ≥ 0.70 (indicating 'high quality').
Analysis of chromosome X. Several cohorts in the primary GWAS did not have X chromosome variant data, specifically, some GCAN-based cohorts (fre1, ukd1, usa1, gns2) and were excluded. Imputation was performed separately from the autosomes 35 . Chromosome X variants in the pseudoautosomal regions were excluded before imputation. SNPs exceeding MAF and INFO score thresholds of 0.01 and 0.70 were retained and analysis was performed with PLINK v1.9 (https:// www.cog-genomics.org/plink2) and Ricopili.
Female-only GWAS.
A supplementary GWAS analysis was conducted on females only to determine the similarity of the results to the primary GWAS analysis, which included both females and males. The cohorts that did not have chromosome X variants to verify sex could not be included (fre1, ukd1, usa1, gns2).
Distance-and LD-based clumping.
The GWAS results implicate genomic regions (loci). To define a locus, first SNPs that met the genome-wide significant threshold of P < 5 × 10 −8 were identified. Second, clumping was used to convert significant SNPs to regions. The SNP with the smallest P value in a genomic window was kept as the index SNP and SNPs in high LD with the index SNP defined the left and right end of the region (SNPs with P < 0.0001 and r 2 > 0.1 within 3-Mb windows). Third, partially or wholly overlapping clumps within 50 kb were identified and merged into one region. Fourth, only loci with additional evidence of association from variants in high LD as depicted by regional plots were retained; furthermore, forest plots needed to confirm the associations based on the majority of cohorts. Finally, conditional analyses were conducted to identify SNPs with associations independent of the top SNP within the genomic section of interest.
Annotation. Genome-wide significant loci were annotated with RegionAnnotator (https://github.com/ivankosmos/RegionAnnotator) to identify known proteincoding genes within loci (Supplementary Table 6 ).
Conditional and joint analyses. Conditional and joint analyses were conducted using GCTA-COJO 15 . GCTA-COJO investigates every locus with a joint combination of independent markers using a genome-wide SNP selection procedure. It takes into account the LD correlations between SNPs and runs a conditional and joint analysis on the basis of conditional P values. After a model optimizing process, the joint effects of all selected SNPs are calculated. The largest subsample from our GWAS (sedk) was used to approximate the underlying LD structure of the investigated lead SNPs. The conditional regression was performed in a stepwise manner using the GCTA software 36 . We analyzed SNPs that had P < 5 × 10 −8 (Supplementary Table 5 ).
Multi-trait-based conditional and joint analyses.
To separate marginal effects from conditional effects (that is, the effect of a risk factor on an outcome controlling for the effect of another risk factor), we performed a multi-trait-based conditional and joint analysis (GCTA-mtCOJO) 18 using an extension of the GCTA software (http://cnsgenomics.com/software/gcta) 36 (Supplementary Table 8 ). This method uses summary-level data to perform the conditional analysis. We conditioned the results of our anorexia nervosa GWAS on GWAS results for education years 37 , type 2 diabetes 38 , HDL cholesterol 39 , BMI (C.H. et al., manuscript in preparation), schizophrenia 40 and neuroticism 41 . We again used the individual-level genotype data from our largest cohort (sedk) to approximate the underlying LD structure. As a first step, the method performs a generalized summary data-based Mendelian randomization (GSMR) analysis (http://cnsgenomics.com/software/gsmr) to test for causal association between the outcome (that is, anorexia nervosa) and the risk factor (for example, schizophrenia). We removed potentially pleiotropic SNPs from this analysis by the heterogeneity in dependent instruments (HEIDI) outlier method 18 . Pleiotropy is the phenomenon when a single locus directly affects several phenotypes. The power of the HEIDI outlier method is dependent on the sample size of the GWAS. Pleiotropic SNPs are defined as the SNPs that show an effect on the outcome that significantly diverges from that expected under a causal model. Second, the GCTA-mtCOJO method calculates the genetic correlation between the exposure and the outcome using LDSC (https://github.com/bulik/ldsc) to adjust for genetic overlap 19, 20 . It also uses the intercept of the bivariate LDSC to account for potential sample overlap 19, 20 . As a result, GCTA-mtCOJO calculates conditional betas, conditional standard errors and conditional P values. Subsequently, we clumped the conditional GWAS results using the standard PLINK v.1.9
42 algorithm (SNPs with P < 0.0001 and r 2 > 0.1 within 3-Mb windows) to investigate whether any of the genome-wide significant loci showed dependency on genetic variation associated with other phenotypes. As described previously 18 , the GCTA-mtCOJO analysis requires the estimates of b xy of the covariate risk factors on the target risk factor and disease, r g of the covariate risk factors, heritability (h 2 SNP ) for the covariate risk factors and the sampling covariance between SNP effects estimated from potentially overlapping samples.
eQTL and chromosome conformation capture (Hi-C) interactions. Although GWAS findings are informative genome-wide, identifying strong hypotheses about their connections to specific genes is not straightforward. The lack of direct connections to genes constrains subsequent experimental modeling and efforts to develop improved therapeutics. Genomic location is often used to connect significant SNPs to genes, but this is problematic because GWAS loci usually contain many correlated and highly significant SNP associations over hundreds of kilobases. Moreover, the three-dimensional arrangement of chromosomes in cell nuclei enables regulatory interactions between genomic regions that are located far apart 43 . Chromosome conformation capture methods, such as Hi-C, enable identification of three-dimensional interactions in vivo 44, 45 and can clarify GWAS findings. For example, an intergenic region associated with multiple cancers was shown to be an enhancer for MYC through a long-range chromatin loop 46, 47 , intronic FTO variants are robustly associated with body mass but influence expression of distal genes through long-range interactions 48 , and Hi-C was used previously 49 to assess the three-dimensional chromatin interactome in fetal brain and connections of some schizophrenia associations to specific genes were found in the study.
To gain a better understanding of the three-dimensional organization of chromatin in the brain and to evaluate disease relevance, we applied Hi-C 50 to post-mortem samples (n = 3 samples of the adult temporal cortex). Details on methodology, data processing, quality control and statistical models used for these analyses have been published elsewhere 51 . We generated sufficient reads to enable a kilobase-resolution map of the chromatin interactome from adult humans. We generated tissue RNA-sequencing, total-stranded RNA-sequencing, chromatin immunprecipitation followed by sequencing (H3K27ac, H3K4me3 and CTCF) and open chromatin data (assay for transpose-accessible chromatin using sequencing; ATAC-seq) for the adult brain to help to interpret the Hi-C results. We also integrated brain expression and eQTL data from GTEx to aid these analyses. The Hi-C analysis is unbiased in that all chromatin interactions that pass a confidence threshold are considered when evaluating the associations between SNPs and genes (that is, it is not a capture experiment where only candidate SNP-to-gene associations are evaluated).
Similar to a previous study 49 , we used Hi-C data generated from human adult brain to identify genes implicated by three-dimensional functional interactomics (Supplementary Fig. 5 ). These Hi-C data (n = 3, anterior temporal cortex) contain more than 103,000 high-confidence, regulatory chromatin interactions 51 . These interactions capture the physical proximity of two regions of the genome in brain nuclei (anchors, 10 kb resolution), although they are separated by 20 kb to 2 Mb in genomic distance. We focused on the regulatory subset of E-P or P-P (E, enhancer; P, promoter) chromatin interactions (with P defined by the location of an open chromatin anchor near the transcription start site of an adult brain-expressed transcript and E defined by the overlap with open chromatin in adult brain plus either H3K27ac or H3K4me3 histone marks). The presence of a regulatory chromatin interaction from a GWAS locus to a gene provides a strong hypothesis about SNP-to-gene regulatory functional interactions.
SNP-based heritability estimation. LDSC software (https://github.com/bulik/ldsc) and methods were used to estimate SNP-based heritabilities for each cohort and overall 19, 20 . We used precomputed LD scores based on the 1000 Genomes Project European ancestry samples 34 (directly downloaded from https://github.com/bulik/ ldsc). The liability scale estimate assumed a population prevalence of 0.9-4% for anorexia nervosa 2, 3 .
Polygenic risk scoring for within-trait predictions. Polygenic leave-one-dataset-out analysis, using PRSice v2.1.3 52 , was conducted in the first instance to identify any extreme outlying datasets. In addition, it enabled the evaluation of the association between anorexia nervosa PRS and anorexia nervosa risk in an independent cohort as a means of replication of the GWAS results. We derived a PRS for anorexia nervosa from the meta-analysis of all datasets except for the target cohort, and then applied the PRS to the target cohort to predict affected status ( Supplementary Fig. 16 ). Logistic regression was performed, including as covariates the first five ancestry components and any other principal components that were significantly associated with the phenotype in the target cohort, and the target cohort was split into deciles based on anorexia nervosa PRS, for which decile 1, which consisted of those with the lowest anorexia nervosa PRS, served as the reference.
Anorexia nervosa subtype analysis. PRS analyses were conducted with anorexia nervosa subgroups to investigate prediction of case status across the subtypes. For this, we split the cases of anorexia nervosa into two groups based on whether binge eating was present. First, GWAS meta-analyses were conducted for anorexia nervosa with binge eating compared to controls (2,381 cases and 10,249 controls; k = 3 datasets: aunz, chop, usa2) and anorexia nervosa with no binge eating compared to controls (2,262 cases and 10,254 controls; k = 3 datasets: aunz, chop, usa2). Controls were randomly split between analyses to maintain independence ( Supplementary Fig. 6 ). Genetic correlation analysis using LDSC 19, 20 was conducted to examine the potential genetic overlap of the two anorexia nervosa subtypes (Supplementary Table 9 ). Second, using PRSice 52 , we calculated PRS for each anorexia nervosa subtype separately in the three target cohorts for which anorexia nervosa subtype data were available. Finally, mean PRS scores were estimated for each subtype by cohort after accounting for covariates in R. Subtype phenotyping is described in the Supplementary Note.
Males.
To assess whether sex-specific differences in genetic risk load exist for anorexia nervosa, we calculated PRS, using PRSice 52 , from a GWAS meta-analysis performed on females only (14,898 cases and 27,545 controls) and applied it to a male-only target cohort (447 cases and 20,347 controls) to predict affected status.
Genetic correlations in the cross-trait analysis. Common variant-based genetic correlation (SNP-r g ) analysis measures the extent to which two traits or disorders share common genetic variation. SNP-r g between anorexia nervosa and 447 traits (422 from an internally curated dataset and 25 from LDHub 53 ) were tested using GWAS summary statistics using an analytical extension of LDSC 19, 20 . The sources of the summary statistics files (PMID, DOI or unpublished results) used in the LDSC are provided in Supplementary Table 10 . When there were multiple summary statistics files available for a trait, significant SNP-r g reported in the main text were chosen based on the largest sample size and/or matching ancestry with our sample (that is, European ancestry).
Genetic correlations with anorexia nervosa corrected for BMI were carried out to investigate whether the observed genetic correlations between anorexia nervosa and metabolic phenotypes were attributable to BMI or partially independent. We used GCTA-mtCOJO 18 to perform a GWAS analysis for anorexia nervosa conditioning on BMI using BMI summary data from our UK Biobank analysis (described in the next section) to derive anorexia nervosa GWAS summary statistics corrected for the common variants genetic component of BMI (Supplementary Tables 14, 15) .
GWAS of related traits in UK Biobank
. Several GWAS analyses were carried out for traits using data from the UK Biobank to allow us to investigate body composition genetics in healthy individuals without a psychiatric or weight-altering disorder or individuals who were taking weight-altering medication. We also used UK Biobank data to carry out GWAS of physical activity level, anxiety and neuroticism (Supplementary Table 20 ). For details, see the Supplementary Note. GSMR analyses. We performed two bidirectional GSMR analyses 18 to test for the causal association first between BMI and anorexia nervosa, and second between type 2 diabetes and anorexia nervosa, using an extension of the GCTA software 36 (Supplementary Table 16 ). We used the individual-level genotype data from our largest cohort (sedk) to approximate the underlying LD structure. We removed potentially pleiotropic SNPs from this analysis by the HEIDI outlier method 18 . Pleiotropic SNPs are defined as the SNPs which show an effect on the outcome that significantly diverges from the one expected under a causal model. The method uses the intercept of the bivariate LD score regression to account for potential sample overlap 19, 20 . As a rule of thumb, GSMR requires GWAS to have at least ten genome-wide significant hits. We lowered the threshold for this requirement to eight SNPs in our analyses of anorexia nervosa as an exposure and BMI or type 2 diabetes as an outcome. Results, therefore, should be interpreted with caution. Moreover, we investigated bidirectional conditional effects between BMI or type 2 diabetes and anorexia nervosa. We used GCTA-mtCOJO to perform a GWAS analysis for anorexia nervosa conditioning on BMI using summary data from our UK Biobank analysis or type 2 diabetes using summary data 38 . Our anorexia nervosa GWAS and the BMI and type 2 diabetes GWAS analyses are based on independent samples. For BMI, we also reran the GSMR analysis using the BMI-adjusted anorexia nervosa GWAS summary data from the GCTA-mtCOJO analysis.
Gene-wise analysis. MAGMA v.1.06 54 (http://ctg.cncr.nl/software/magma) was used to perform a gene-wise test of association with anorexia nervosa based on GWAS summary statistics. MAGMA generates gene-based P values by combining SNP-based P values within a gene while accounting for LD. To include regulatory regions, SNPs are mapped to genes within a 35-kb upstream and 10-kb downstream window, and the gene P value is obtained using the multi = snp-wise model, which aggregates mean and top SNP association models. We tested 19,846 ENSEMBL genes, including the X chromosome (Supplementary Table 11 ). As a reference panel for the underlying LD structure, we used 1000 Genomes European data phase 3 34 .
Pathway analysis. MAGMA v.1.06 54 was used to perform a competitive pathway analysis, testing whether genes associated with anorexia nervosa were more enriched in a given pathway than all other pathways. The analysis included chromosome X. Biological pathways were defined using gene ontology pathways and canonical pathways from MSigDB v.6.1 55 , and psychiatric pathways mined from the literature. A total of 7,268 pathways were tested (Supplementary Table 12 ).
Partitioned heritability. Partitioned heritability was investigated using stratified LDSC 26 , which estimates the per-SNP contribution to overall SNP-heritability (SNP-h 2 ) across various functional annotation categories of the genome (Supplementary Fig. 7 ). It accounts for linked markers and uses a 'full baseline model' of 24 annotations that are not specific to any cell type. We excluded the MHC region in our analysis. SNP-h 2 can be partitioned in two different ways: a non-cell type-specific and a cell type-specific manner. Partitioned heritability analysis was used to test for cell type-specific enrichment in the GWAS of anorexia nervosa among 10 cell type groups: adrenal tissue and pancreas, cardiovascular tissue, central nervous system, connective tissue and bone, gastrointestinal tissue, immune and hematopoietic tissues, kidney, liver, skeletal muscle and other tissues, which includes adipose tissue ( Supplementary Fig. 8 ).
Gene expression. We conducted a series of gene expression analyses as described in the Supplementary Note. Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The policy of the PGC is to make genome-wide summary results public. Genomewide summary statistics for the meta-analysis are freely downloadable from the website of the PGC (http://www.med.unc.edu/pgc/results-and-downloads). Individual-level data are deposited in dbGaP (http://www.ncbi.nlm.nih.gov/gap) for ANGI-ANZ/SE/US (accession number phs001541.v1.p1) and CHOP/PFCG (accession number phs000679.v1.p1). ANGI-DK individual-level data are not available in dbGaP owing to Danish laws, but are available through collaboration with principal investigators of the Danish institutions. GCAN/WTCCC3 individuallevel data are deposited in EGA (https://www.ebi.ac.uk/ega) (accession number EGAS00001000913) with the exception of the Netherlands and USA/Canada; data from these countries are available through collaboration with principal investigators of institutions in these countries. UK Biobank individual-level data can be applied for on the UK Biobank website (http://www.ukbiobank.ac.uk/register-apply). 
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Data collection
No software was used to compile the code. All code is available upon reasonable requests from the analysts and senior author.
Data analysis
The manuscript includes information on all software and versions used. All software used is publicly available, including Plink (https:// www.coggenomics.org/plink2/), Ricopili (https://sites.google.com/a/broadinstitute.org/ricopili/download), LDSC (https://github.com/ bulik/ldsc), METAL (http://csg.sph.umich.edu/abecasis/metal/download/), R (https://www.r-project.org/), MAGMA (https://ctg.cncr.nl/ software/magma), S-PrediXcan (https://github.com/hakyimlab/PrediXcan), GCTA (https://cnsgenomics.com/software/gcta/#Download), PRSice (http://prsice.info/), and GSMR (http://cnsgenomics.com/software/gsmr/).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
